Imfinzi Bladder Cancer Approval Marks Breakthro...

By HEOR Staff Writer

May 29, 2026

The Imfinzi bladder cancer approval by the FDA now offers a new immunotherapy option for adults with BCG-naïve, high-risk non-muscle-invasive bladder cancer when combined with standard BCG induction and maintenance therapy. This Imfinzi bladder...